431 related articles for article (PubMed ID: 35672862)
1. Targeting tumor-associated macrophages for cancer treatment.
Li M; He L; Zhu J; Zhang P; Liang S
Cell Biosci; 2022 Jun; 12(1):85. PubMed ID: 35672862
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumor-associated macrophages for cancer immunotherapy.
Cao X; Lai SWT; Chen S; Wang S; Feng M
Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
4. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
5. Targeting tumor-associated macrophages as an antitumor strategy.
Cheng N; Bai X; Shu Y; Ahmad O; Shen P
Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
[TBL] [Abstract][Full Text] [Related]
6. The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology.
Vanmeerbeek I; Govaerts J; Laureano RS; Sprooten J; Naulaerts S; Borras DM; Laoui D; Mazzone M; Van Ginderachter JA; Garg AD
Cells; 2022 Dec; 11(23):. PubMed ID: 36497148
[TBL] [Abstract][Full Text] [Related]
7. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
Zhan C; Jin Y; Xu X; Shao J; Jin C
Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
[TBL] [Abstract][Full Text] [Related]
8. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
Xu L; Xie X; Luo Y
Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy.
Liu L; Chen G; Gong S; Huang R; Fan C
Front Immunol; 2023; 14():1274547. PubMed ID: 38022518
[TBL] [Abstract][Full Text] [Related]
10. Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor-Glioma Therapy?
Tong N; He Z; Ma Y; Wang Z; Huang Z; Cao H; Xu L; Zou Y; Wang W; Yi C; Yin Z; Wang Q
Front Cell Dev Biol; 2021; 9():706286. PubMed ID: 34368156
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor-associated macrophages: A potential treatment for solid tumors.
Chen Y; Jin H; Song Y; Huang T; Cao J; Tang Q; Zou Z
J Cell Physiol; 2021 May; 236(5):3445-3465. PubMed ID: 33200401
[TBL] [Abstract][Full Text] [Related]
12. Macrophage targeting in cancer.
Lopez-Yrigoyen M; Cassetta L; Pollard JW
Ann N Y Acad Sci; 2021 Sep; 1499(1):18-41. PubMed ID: 32445205
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy.
Tan Y; Wang M; Zhang Y; Ge S; Zhong F; Xia G; Sun C
Front Oncol; 2021; 11():693517. PubMed ID: 34178692
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
Musick M; Yu X
Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
[TBL] [Abstract][Full Text] [Related]
15. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tumor-Associated Macrophages in Cancer Immunotherapy.
Petty AJ; Owen DH; Yang Y; Huang X
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771482
[TBL] [Abstract][Full Text] [Related]
17. Targeting macrophages: a novel treatment strategy in solid tumors.
Liu M; Liu L; Song Y; Li W; Xu L
J Transl Med; 2022 Dec; 20(1):586. PubMed ID: 36510315
[TBL] [Abstract][Full Text] [Related]
18. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
[TBL] [Abstract][Full Text] [Related]
19. Progress in Tumor-Associated Macrophages: From Bench to Bedside.
Wang Y; Lin YX; Qiao SL; Wang J; Wang H
Adv Biosyst; 2019 Feb; 3(2):e1800232. PubMed ID: 32627370
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers.
Wu D; Liu X; Mu J; Yang J; Wu F; Zhou H
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
